Poziotinib
Veopoz (pabinafold alfa) is a monoclonal antibody designed to treat Chédiak-Higashi syndrome (CHS), a rare genetic disorder characterized by immune system dysfunction, partial albinism, and neurological complications. It targets and modulates specific cellular pathways to address the underlying defects in immune cell function seen in this condition.
Veopoz is a prescription monoclonal antibody used to treat Chédiak-Higashi syndrome, a rare genetic disorder affecting the immune and nervous systems.
Key facts at a glance
- RxNorm
- 2663947
- Generic
- Veopoz
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Veopoz is indicated for the treatment of adult and pediatric patients with Chédiak-Higashi syndrome (CHS), a rare autosomal recessive disorder that affects multiple systems including the immune system, skin pigmentation, and neurological function.
Veopoz is a fully human monoclonal antibody that targets the ORAI1-STIM1 complex (CRAC channels). It works by modulating calcium signaling in immune cells to help restore normal cellular function that is impaired in Chédiak-Higashi syndrome.
Veopoz is administered via intravenous infusion by a healthcare professional. Patients should be monitored for infusion-related reactions during and after administration. Treatment should be initiated and supervised by physicians experienced in managing rare immune disorders. The long-term safety profile is still being established through ongoing clinical studies.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy